2025년 03월 03일 월요일
 
 
  현재위치 > 뉴스지닷컴 > Science & Technology

랜섬웨어부터 돼지도살까지... 노련해진 사기행각

 

정치

 

경제

 

사회

 

생활

 

문화

 

국제

 

과학기술

 

연예

 

스포츠

 

자동차

 

부동산

 

경영

 

영업

 

미디어

 

신상품

 

교육

 

학회

 

신간

 

공지사항

 

칼럼

 

캠페인
한살림 ‘우리는 한쌀림’ 쌀 소비 캠페인 시...
1000만원짜리 인공와우, 건강보험 지원 ‘평...
- - - - - - -
 

GE Healthcare Announces Multi-Year Agreement with SQM to Secure Iodine Supply for Contrast Media

Enables GE Healthcare to secure increasing supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) imaging procedures
뉴스일자: 2022-10-14

Photo : Iodine prills – produced by SQM

CHALFONT ST. GILES, ENGLAND-- October 14, 2022 -- GE Healthcare’s Pharmaceutical Diagnostics business has announced a long-term agreement with Chile-based mining company, Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchange: SQM-B, SQM-A), to secure its supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) procedures globally. The agreement will see SQM increase supply of iodine raw material year-on-year and is part of GE Healthcare’s broader commitment and investment plan to enable the production of 30 million more patient doses of iodinated contrast media annually by 2025.

The growing global prevalence of chronic disorders has driven significant growth in CT procedures, leading to increased global demand for iodinated contrast media, used to enhance visualization of organs, blood vessels and tissues across clinical care pathways. GE Healthcare is also investing in production capacity to help meet this growing demand, including a new $30 million manufacturing line at its Cork, Ireland, contrast media production facility, which opens this week.

Kevin O’Neill, President and CEO, GE Healthcare Pharmaceutical Diagnostics, said: “We expect global demand for iodinated contrast media to double in the next 10 years. As an industry leader, we understand our responsibility to help meet this growing demand from customers and patients by investing in production capacity and securing higher volumes of iodine raw material. As one of the largest consumers of iodine globally we value our longstanding relationship with SQM, an important partner for us.”

Pablo Altimiras, Executive Vice President of Iodine and Nitrates, SQM, said: “We’re pleased to continue our relationship with GE Healthcare - a key customer for us for more than 40 years. As one of the largest producers of iodine worldwide with approximately 24 percent of our production used for X-ray contrast media, we are committed to the iodine industry and will continue to improve quality and increase capacity to ensure the reliability of supply, which is essential to so many sectors, including healthcare.”

GE Healthcare Pharmaceutical Diagnostics develops and manufactures imaging agents used to support over 100 million procedures per year, equivalent to three patient procedures every second. All stages of its contrast media manufacturing, from development of API to finished product, are managed entirely by GE Healthcare, adhering to current Good Manufacturing Practices (cGMP). With over 4000 employees globally and seven manufacturing sites, the business also develops and supplies radiopharmaceuticals used to support diagnosis, monitoring and treatment selection across Neurology, Cardiology and Oncology clinical pathways.



 전체뉴스목록으로

Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea
SES Enables Viasat Energy Services’ Asia-Pacific Customer to Experience High-Performance Connectivity
Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery
Xsolla and AppsFlyer Unveil Custom Integration to Boost Mobile Game Web Shop Performance
Cymulate Reveals Next-level AI Automation for Threat Exposure Validation
Bentley Systems Issues Call for Nominations for the 2025 Going Digital Awards
LG Showcases Digital Signage Solutions Tailored for Diverse B2B Sectors at ISE 2025

 

Galderma’s Nemluvio Approved in the European Union for Moderate-to-Se...
Pine Island New Energy Partners and Type One Energy Announce Collabora...
FPT Launches New Office in Pangyo, Silicon Valley of South Korea
Experian and ValidMind Partner to Transform Model Risk Management
Personal Intelligence Network: PIN AI Launches to Protect Personal Dat...
Accelera to Power 100 MW Electrolyzer System for bp’s Lingen Green Hy...
Type One Energy and TVA Sign Agreement Focused on First Fusion Power P...

 


공지사항
알프롬 Alfrom 중문 표기 阿尔福牧
베네프롬 베네인투 중문 표시 宝乃福牧 宝乃因托
뉴스지 한자 표기에 대만식 음차 표기 '纽斯集 니우시지' 병기
뉴스그룹 정보 미디어 부문 상표등록
알프롬 계열 상표, 상표등록 완료

 

회사소개 | 인재채용 | 이용약관 | 개인정보취급방침 | 청소년보호정책 | 책임한계와 법적고지 | 이메일주소무단수집거부 | 고객센터

기사제보 이메일 news@newsji.com, 전화 050 2222 0002, 팩스 050 2222 0111, 주소 : 서울 구로구 가마산로 27길 60 1-37호

인터넷뉴스서비스사업등록 : 서울 자00447, 등록일자 : 2013.12.23., 뉴스배열 및 청소년보호의 책임 : 대표 CEO

Copyright ⓒ All rights reserved..